It is an?antibiotic?medication used it to treat adults with community-acquired bacterial?pneumonia.
The global market for Lefamulin is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Lefamulin market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Lefamulin market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Lefamulin market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Lefamulin market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Lefamulin players cover Nabriva, Sumitomo Pharma and Sinovant Sciences. etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Lefamulin market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Lefamulin market, with both quantitative and qualitative data, to help readers understand how the Lefamulin market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in L.
Market Segmentation:
The study segments the Lefamulin market and forecasts the market size by Usage (Take Orally and Injection,), by Application (Medicine and Scientific Research.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by usage
Take Orally
Injection
Segmentation by application
Medicine
Scientific Research
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Nabriva
Sumitomo Pharma
Sinovant Sciences
Chapter Introduction
Chapter 1: Scope of Lefamulin, Research Methodology, etc.
Chapter 2: Executive Summary, global Lefamulin market size (sales and revenue) and CAGR, Lefamulin market size by region, by usage, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Lefamulin sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Lefamulin sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by usage, and usage.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Lefamulin market size forecast by region, by country, by usage, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Nabriva, Sumitomo Pharma and Sinovant Sciences, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lefamulin Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Lefamulin by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Lefamulin by Country/Region, 2017, 2022 & 2028
2.2 Lefamulin Segment by Usage
2.2.1 Take Orally
2.2.2 Injection
2.3 Lefamulin Sales by Usage
2.3.1 Global Lefamulin Sales Market Share by Usage (2017-2022)
2.3.2 Global Lefamulin Revenue and Market Share by Usage (2017-2022)
2.3.3 Global Lefamulin Sale Price by Usage (2017-2022)
2.4 Lefamulin Segment by Application
2.4.1 Medicine
2.4.2 Scientific Research
2.5 Lefamulin Sales by Application
2.5.1 Global Lefamulin Sale Market Share by Application (2017-2022)
2.5.2 Global Lefamulin Revenue and Market Share by Application (2017-2022)
2.5.3 Global Lefamulin Sale Price by Application (2017-2022)
3 Global Lefamulin by Company
3.1 Global Lefamulin Breakdown Data by Company
3.1.1 Global Lefamulin Annual Sales by Company (2020-2022)
3.1.2 Global Lefamulin Sales Market Share by Company (2020-2022)
3.2 Global Lefamulin Annual Revenue by Company (2020-2022)
3.2.1 Global Lefamulin Revenue by Company (2020-2022)
3.2.2 Global Lefamulin Revenue Market Share by Company (2020-2022)
3.3 Global Lefamulin Sale Price by Company
3.4 Key Manufacturers Lefamulin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lefamulin Product Location Distribution
3.4.2 Players Lefamulin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Lefamulin by Geographic Region
4.1 World Historic Lefamulin Market Size by Geographic Region (2017-2022)
4.1.1 Global Lefamulin Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Lefamulin Annual Revenue by Geographic Region
4.2 World Historic Lefamulin Market Size by Country/Region (2017-2022)
4.2.1 Global Lefamulin Annual Sales by Country/Region (2017-2022)
4.2.2 Global Lefamulin Annual Revenue by Country/Region
4.3 Americas Lefamulin Sales Growth
4.4 APAC Lefamulin Sales Growth
4.5 Europe Lefamulin Sales Growth
4.6 Middle East & Africa Lefamulin Sales Growth
5 Americas
5.1 Americas Lefamulin Sales by Country
5.1.1 Americas Lefamulin Sales by Country (2017-2022)
5.1.2 Americas Lefamulin Revenue by Country (2017-2022)
5.2 Americas Lefamulin Sales by Usage
5.3 Americas Lefamulin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lefamulin Sales by Region
6.1.1 APAC Lefamulin Sales by Region (2017-2022)
6.1.2 APAC Lefamulin Revenue by Region (2017-2022)
6.2 APAC Lefamulin Sales by Usage
6.3 APAC Lefamulin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Lefamulin by Country
7.1.1 Europe Lefamulin Sales by Country (2017-2022)
7.1.2 Europe Lefamulin Revenue by Country (2017-2022)
7.2 Europe Lefamulin Sales by Usage
7.3 Europe Lefamulin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lefamulin by Country
8.1.1 Middle East & Africa Lefamulin Sales by Country (2017-2022)
8.1.2 Middle East & Africa Lefamulin Revenue by Country (2017-2022)
8.2 Middle East & Africa Lefamulin Sales by Usage
8.3 Middle East & Africa Lefamulin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lefamulin
10.3 Manufacturing Process Analysis of Lefamulin
10.4 Industry Chain Structure of Lefamulin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lefamulin Distributors
11.3 Lefamulin Customer
12 World Forecast Review for Lefamulin by Geographic Region
12.1 Global Lefamulin Market Size Forecast by Region
12.1.1 Global Lefamulin Forecast by Region (2023-2028)
12.1.2 Global Lefamulin Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Lefamulin Forecast by Usage
12.7 Global Lefamulin Forecast by Application
13 Key Players Analysis
13.1 Nabriva
13.1.1 Nabriva Company Information
13.1.2 Nabriva Lefamulin Product Offered
13.1.3 Nabriva Lefamulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Nabriva Main Business Overview
13.1.5 Nabriva Latest Developments
13.2 Sumitomo Pharma
13.2.1 Sumitomo Pharma Company Information
13.2.2 Sumitomo Pharma Lefamulin Product Offered
13.2.3 Sumitomo Pharma Lefamulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sumitomo Pharma Main Business Overview
13.2.5 Sumitomo Pharma Latest Developments
13.3 Sinovant Sciences
13.3.1 Sinovant Sciences Company Information
13.3.2 Sinovant Sciences Lefamulin Product Offered
13.3.3 Sinovant Sciences Lefamulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sinovant Sciences Main Business Overview
13.3.5 Sinovant Sciences Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Lefamulin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Lefamulin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Take Orally
Table 4. Major Players of Injection
Table 5. Global Lefamulin Sales by Usage (2017-2022) & (L)
Table 6. Global Lefamulin Sales Market Share by Usage (2017-2022)
Table 7. Global Lefamulin Revenue by Usage (2017-2022) & ($ million)
Table 8. Global Lefamulin Revenue Market Share by Usage (2017-2022)
Table 9. Global Lefamulin Sale Price by Usage (2017-2022) & (US$/L)
Table 10. Global Lefamulin Sales by Application (2017-2022) & (L)
Table 11. Global Lefamulin Sales Market Share by Application (2017-2022)
Table 12. Global Lefamulin Revenue by Application (2017-2022)
Table 13. Global Lefamulin Revenue Market Share by Application (2017-2022)
Table 14. Global Lefamulin Sale Price by Application (2017-2022) & (US$/L)
Table 15. Global Lefamulin Sales by Company (2020-2022) & (L)
Table 16. Global Lefamulin Sales Market Share by Company (2020-2022)
Table 17. Global Lefamulin Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Lefamulin Revenue Market Share by Company (2020-2022)
Table 19. Global Lefamulin Sale Price by Company (2020-2022) & (US$/L)
Table 20. Key Manufacturers Lefamulin Producing Area Distribution and Sales Area
Table 21. Players Lefamulin Products Offered
Table 22. Lefamulin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Lefamulin Sales by Geographic Region (2017-2022) & (L)
Table 26. Global Lefamulin Sales Market Share Geographic Region (2017-2022)
Table 27. Global Lefamulin Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Lefamulin Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Lefamulin Sales by Country/Region (2017-2022) & (L)
Table 30. Global Lefamulin Sales Market Share by Country/Region (2017-2022)
Table 31. Global Lefamulin Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Lefamulin Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Lefamulin Sales by Country (2017-2022) & (L)
Table 34. Americas Lefamulin Sales Market Share by Country (2017-2022)
Table 35. Americas Lefamulin Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Lefamulin Revenue Market Share by Country (2017-2022)
Table 37. Americas Lefamulin Sales by Type (2017-2022) & (L)
Table 38. Americas Lefamulin Sales Market Share by Usage (2017-2022)
Table 39. Americas Lefamulin Sales by Application (2017-2022) & (L)
Table 40. Americas Lefamulin Sales Market Share by Application (2017-2022)
Table 41. APAC Lefamulin Sales by Region (2017-2022) & (L)
Table 42. APAC Lefamulin Sales Market Share by Region (2017-2022)
Table 43. APAC Lefamulin Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Lefamulin Revenue Market Share by Region (2017-2022)
Table 45. APAC Lefamulin Sales by Usage (2017-2022) & (L)
Table 46. APAC Lefamulin Sales Market Share by Usage (2017-2022)
Table 47. APAC Lefamulin Sales by Application (2017-2022) & (L)
Table 48. APAC Lefamulin Sales Market Share by Application (2017-2022)
Table 49. Europe Lefamulin Sales by Country (2017-2022) & (L)
Table 50. Europe Lefamulin Sales Market Share by Country (2017-2022)
Table 51. Europe Lefamulin Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Lefamulin Revenue Market Share by Country (2017-2022)
Table 53. Europe Lefamulin Sales by Type (2017-2022) & (L)
Table 54. Europe Lefamulin Sales Market Share by Usage (2017-2022)
Table 55. Europe Lefamulin Sales by Application (2017-2022) & (L)
Table 56. Europe Lefamulin Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Lefamulin Sales by Country (2017-2022) & (L)
Table 58. Middle East & Africa Lefamulin Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Lefamulin Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Lefamulin Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Lefamulin Sales by Usage (2017-2022) & (L)
Table 62. Middle East & Africa Lefamulin Sales Market Share by Usage (2017-2022)
Table 63. Middle East & Africa Lefamulin Sales by Application (2017-2022) & (L)
Table 64. Middle East & Africa Lefamulin Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Lefamulin
Table 66. Key Market Challenges & Risks of Lefamulin
Table 67. Key Industry Trends of Lefamulin
Table 68. Lefamulin Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Lefamulin Distributors List
Table 71. Lefamulin Customer List
Table 72. Global Lefamulin Sales Forecast by Region (2023-2028) & (L)
Table 73. Global Lefamulin Sales Market Forecast by Region
Table 74. Global Lefamulin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Lefamulin Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Lefamulin Sales Forecast by Country (2023-2028) & (L)
Table 77. Americas Lefamulin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Lefamulin Sales Forecast by Region (2023-2028) & (L)
Table 79. APAC Lefamulin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Lefamulin Sales Forecast by Country (2023-2028) & (L)
Table 81. Europe Lefamulin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Lefamulin Sales Forecast by Country (2023-2028) & (L)
Table 83. Middle East & Africa Lefamulin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Lefamulin Sales Forecast by Usage (2023-2028) & (L)
Table 85. Global Lefamulin Sales Market Share Forecast by Usage (2023-2028)
Table 86. Global Lefamulin Revenue Forecast by Usage (2023-2028) & ($ Millions)
Table 87. Global Lefamulin Revenue Market Share Forecast by Usage (2023-2028)
Table 88. Global Lefamulin Sales Forecast by Application (2023-2028) & (L)
Table 89. Global Lefamulin Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Lefamulin Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Lefamulin Revenue Market Share Forecast by Application (2023-2028)
Table 92. Nabriva Basic Information, Lefamulin Manufacturing Base, Sales Area and Its Competitors
Table 93. Nabriva Lefamulin Product Offered
Table 94. Nabriva Lefamulin Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 95. Nabriva Main Business
Table 96. Nabriva Latest Developments
Table 97. Sumitomo Pharma Basic Information, Lefamulin Manufacturing Base, Sales Area and Its Competitors
Table 98. Sumitomo Pharma Lefamulin Product Offered
Table 99. Sumitomo Pharma Lefamulin Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 100. Sumitomo Pharma Main Business
Table 101. Sumitomo Pharma Latest Developments
Table 102. Sinovant Sciences Basic Information, Lefamulin Manufacturing Base, Sales Area and Its Competitors
Table 103. Sinovant Sciences Lefamulin Product Offered
Table 104. Sinovant Sciences Lefamulin Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 105. Sinovant Sciences Main Business
Table 106. Sinovant Sciences Latest Developments
List of Figures
Figure 1. Picture of Lefamulin
Figure 2. Lefamulin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lefamulin Sales Growth Rate 2017-2028 (L)
Figure 7. Global Lefamulin Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Lefamulin Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Take Orally
Figure 10. Product Picture of Injection
Figure 11. Global Lefamulin Sales Market Share by Usage in 2021
Figure 12. Global Lefamulin Revenue Market Share by Usage (2017-2022)
Figure 13. Lefamulin Consumed in Medicine
Figure 14. Global Lefamulin Market: Medicine (2017-2022) & (L)
Figure 15. Lefamulin Consumed in Scientific Research
Figure 16. Global Lefamulin Market: Scientific Research (2017-2022) & (L)
Figure 17. Global Lefamulin Sales Market Share by Application (2017-2022)
Figure 18. Global Lefamulin Revenue Market Share by Application in 2021
Figure 19. Lefamulin Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Lefamulin Revenue Market Share by Company in 2021
Figure 21. Global Lefamulin Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Lefamulin Revenue Market Share by Geographic Region in 2021
Figure 23. Global Lefamulin Sales Market Share by Region (2017-2022)
Figure 24. Global Lefamulin Revenue Market Share by Country/Region in 2021
Figure 25. Americas Lefamulin Sales 2017-2022 (L)
Figure 26. Americas Lefamulin Revenue 2017-2022 ($ Millions)
Figure 27. APAC Lefamulin Sales 2017-2022 (L)
Figure 28. APAC Lefamulin Revenue 2017-2022 ($ Millions)
Figure 29. Europe Lefamulin Sales 2017-2022 (L)
Figure 30. Europe Lefamulin Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Lefamulin Sales 2017-2022 (L)
Figure 32. Middle East & Africa Lefamulin Revenue 2017-2022 ($ Millions)
Figure 33. Americas Lefamulin Sales Market Share by Country in 2021
Figure 34. Americas Lefamulin Revenue Market Share by Country in 2021
Figure 35. United States Lefamulin Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Lefamulin Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Lefamulin Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Lefamulin Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Lefamulin Sales Market Share by Region in 2021
Figure 40. APAC Lefamulin Revenue Market Share by Regions in 2021
Figure 41. China Lefamulin Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Lefamulin Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Lefamulin Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Lefamulin Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Lefamulin Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Lefamulin Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Lefamulin Sales Market Share by Country in 2021
Figure 48. Europe Lefamulin Revenue Market Share by Country in 2021
Figure 49. Germany Lefamulin Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Lefamulin Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Lefamulin Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Lefamulin Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Lefamulin Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Lefamulin Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Lefamulin Revenue Market Share by Country in 2021
Figure 56. Egypt Lefamulin Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Lefamulin Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Lefamulin Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Lefamulin Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Lefamulin Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Lefamulin in 2021
Figure 62. Manufacturing Process Analysis of Lefamulin
Figure 63. Industry Chain Structure of Lefamulin
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)